| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000012034 |
| Receipt No. | R000014066 |
| Official scientific title of the study | The effect of continuous glucose monitoring system useing at the diabetes mellitus outpatient clinic |
| Date of disclosure of the study information | 2013/10/15 |
| Last modified on | 2016/10/18 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | The effect of continuous glucose monitoring system useing at the diabetes mellitus outpatient clinic | |
| Title of the study (Brief title) | The effect of CGM at the diabetes mellitus outpatient clinic | |
| Region |
|
|
| Condition | ||
| Condition | Diabetes Mellitus | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To clarify the effect of useing CGM(iPro2)at
the diabetes mellitus outpatient clinic |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Improvement of HbA1c
Improvement of glucose movement Decrease of hypoglycemia |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||||
| No. of arms | 2 | |||
| Purpose of intervention | Treatment | |||
| Type of intervention |
|
|||
| Interventions/Control_1 | With the data of CGM, more suitable medication and life habit are suggested to the patient for better treatment. | |||
| Interventions/Control_2 | Without the data of CGM, more suitable medication and life habit are suggested to the patient for better treatment. | |||
| Interventions/Control_3 | ||||
| Interventions/Control_4 | ||||
| Interventions/Control_5 | ||||
| Interventions/Control_6 | ||||
| Interventions/Control_7 | ||||
| Interventions/Control_8 | ||||
| Interventions/Control_9 | ||||
| Interventions/Control_10 | ||||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Patient whose HbA1c is 6.9-11% for three months.
2.Patients doing nutrition and exercise therapy. 3.Patients doing insulin therapy excluding BOT. |
|||
| Key exclusion criteria | 1.Patients with serious liver,renal,heart,pancreatic insufficiency.
2.Patients with cancer 3.Patients with anemia or plastocytopenia 4.Patients with serious diabetic complications 5.Patients with serious infection 6.Patients before and after the operation 7.Patients of heavy alcoholic drinker 8.Pregnant women 9.Patients with hepatic viruses |
|||
| Target sample size | 34 | |||
| Research contact person | |
| Name of lead principal investigator | Sato Junko |
| Organization | Juntendo University Graduate School of Medicine |
| Division name | Department of Metabolism and Endocrinology |
| Address | 2-1-1Hongo,Bunkyoku,Tokyo |
| TEL | 03-3813-3111 |
| jsato@juntendo.ac.jp | |
| Public contact | |
| Name of contact person | Sato, Junko |
| Organization | Juntendo University Graduate School of Medicine |
| Division name | Department of Metabolism and Endocrinology |
| Address | 2-1-1Hongo,Bunkyoku,Tokyo |
| TEL | 03-3813-3111 |
| Homepage URL | |
| jsato@juntendo.ac.jp | |
| Sponsor | |
| Institute | Juntendo University Graduate School of Medicine, Department of Metabolism and Endocrinology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Juntendo University Graduate School of Medicine, Department of Metabolism and Endocrinology |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | YES |
| Study ID_1 | 12-86 |
| Org. issuing International ID_1 | Juntendo University Hospital |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000014066 |